Prodromal bullous pemphigoid

International Journal of Dermatology
Philina M LambJau-Shyong Deng

Abstract

Prodromal bullous pemphigoid (PBP) can be difficult to diagnose. Early recognition in its early stages may decrease the morbidity and progression of the disease. Clinical presentations and current treatments available for PBP will be described. A retrospective review was performed on 53 patients diagnosed with PBP. Overall, the average disease duration of PBP was 11.8 months. The average age of presentation of PBP was 70.8 years. The most common presentations were urticaria-like plaques (67.9%), eczema-like lesions (11.3%), and dermatitis herpetiformis-like lesions (9.4%). The majority of patients responded well to low doses of systemic corticosteroids, tetracycline, and/or high potency topical corticosteroids. Patients with PBP tend to be in their sixth or early seventh decade of life and, on average, the duration of disease is 1 year. The most common presentation of disease is urticaria-like plaques.

References

Nov 1, 1979·The British Journal of Dermatology·J A Savin
Apr 1, 1992·Journal of the American Academy of Dermatology·V A Venning, F Wojnarowska
Nov 1, 1989·Journal of the American Academy of Dermatology·M TaniH Masaki
Oct 1, 1988·International Journal of Dermatology·D A AmatoJ Zitelli
Apr 1, 1982·Journal of the American Academy of Dermatology·G TappeinerK Holubar
Mar 1, 1983·Journal of the American Academy of Dermatology·C CrottyS A Muller
Aug 1, 1983·The British Journal of Dermatology·D J Barker
Jan 1, 1981·Archives of Dermatology·K Kuokkanen, H Helin
Jul 1, 1981·Journal of the American Academy of Dermatology·C W YungA L Lorincz
Jun 1, 1994·Journal of the American Academy of Dermatology·E RuizE A Abell
Aug 1, 1993·Journal of the American Academy of Dermatology·R StrohalK Wolff
Jan 1, 1993·Journal of the American Academy of Dermatology·A SaitohK Tamaki
Dec 1, 1995·The British Journal of Dermatology·N J Korman, S G Woods
Jan 1, 1997·Journal of the American Academy of Dermatology·B HornschuhD Zillikens
Apr 29, 1998·Archives of Dermatology·J C RoujeauP Bernard
Oct 8, 1998·Archives of Dermatology·N J Korman
Nov 12, 1998·Journal of the American Academy of Dermatology·J Alonso-LlamazaresL E Gibson
Nov 14, 2001·Dermatologic Clinics·N J Korman
Feb 1, 2002·The New England Journal of Medicine·Pascal JolyUNKNOWN Bullous Diseases French Study Group
Feb 1, 2002·The New England Journal of Medicine·Robert S Stern
Mar 21, 2002·Archives of Dermatology·Nonhlanhla P KhumaloGudula Kirtschig
Jul 12, 2002·The New England Journal of Medicine·Michael R Ardern-JonesFenella Wojnarowska

❮ Previous
Next ❯

Citations

Mar 25, 2011·Indian Journal of Dermatology·Maria CrisanDiana Crisan
Apr 27, 2012·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Luca FaniaMichael Hertl
May 17, 2011·Journal of the American Academy of Dermatology·Gilles Safa, Laure Darrieux
May 18, 2010·The Veterinary Clinics of North America. Small Animal Practice·Laurel J Gershwin
Mar 16, 2012·The Journal of Investigative Dermatology·Pascal JolyJacques Bénichou
Jan 24, 2008·International Journal of Dermatology·Philina M LambJau-Shyong Deng
Jun 20, 2012·The British Journal of Dermatology·R della TorreL Borradori
Oct 23, 2016·Drugs & Aging·Minhee KimDédée F Murrell
Jun 30, 2009·The Journal of Dermatological Treatment·Caihong SunHeng Gu
Sep 5, 2018·Frontiers in Medicine·Khalaf Kridin, Ralf J Ludwig
Mar 16, 2012·Journal of Cutaneous Medicine and Surgery·Farheen MussaniCheryl F Rosen
Nov 2, 2017·International Journal of Dermatology·Khalaf Kridin, Reuven Bergman
Nov 22, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·N YoshimotoH Ujiie
Mar 19, 2021·JAAD Case Reports·George AttehRon J Feldman
Mar 29, 2021·Archives of Dermatological Research·Xin-Xing JinYa-Gang Zuo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.